Page last updated: 2024-10-31

mitoxantrone and Leiomyosarcoma, Epithelioid

mitoxantrone has been researched along with Leiomyosarcoma, Epithelioid in 3 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"Twenty-nine evaluable patients with metastatic or recurrent leiomyosarcoma or malignant mixed mesodermal tumors of the uterus were treated with mitoxantrone 12 mg/m2 every 3 weeks."5.06Mitoxantrone in the treatment of advanced uterine sarcoma. A phase II trial of the Gynecologic Oncology Group. ( Adcock, L; Beecham, J; Bundy, BN; Muss, HB, 1990)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Görich, J1
Brensing, KA1
Kunze, V1
Sokiranski, R1
Rilinger, N1
Müller-Miny, H1
Brambs, HJ1
Saglik, Y1
Icli, F1
Uluoglu, O1
Isiklar, ZU1
Muss, HB1
Bundy, BN1
Adcock, L1
Beecham, J1

Trials

1 trial available for mitoxantrone and Leiomyosarcoma, Epithelioid

ArticleYear
Mitoxantrone in the treatment of advanced uterine sarcoma. A phase II trial of the Gynecologic Oncology Group.
    American journal of clinical oncology, 1990, Volume: 13, Issue:1

    Topics: Adult; Aged; Drug Evaluation; Female; Humans; Leiomyosarcoma; Middle Aged; Mitoxantrone; Multicenter

1990

Other Studies

2 other studies available for mitoxantrone and Leiomyosarcoma, Epithelioid

ArticleYear
[Percutaneous drainage of refractory necrotizing tumors: experience in 9 patients].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1995, Volume: 163, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Cystadenocarcinoma; Drainage; Female; His

1995
Leiomyosarcoma of the great saphenous vein.
    International orthopaedics, 1992, Volume: 16, Issue:2

    Topics: Combined Modality Therapy; Female; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Mitoxantrone

1992